Health Catalyst (Health Catalyst) Risk Assessment

View and export this data going back to 2019. Start your Free Trial

What is Health Catalyst Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Health Catalyst is: High Risk: High uncertainty.

Competitive Comparison of Health Catalyst's Risk Assessment

For the Health Information Services subindustry, Health Catalyst's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Health Catalyst's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Health Catalyst's Risk Assessment falls into.

Health Catalyst (NAS:HCAT) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Health Catalyst Risk Assessment Related Terms

Thank you for viewing the detailed overview of Health Catalyst's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Health Catalyst (Health Catalyst) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Health Catalyst Inc (NAS:HCAT) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

2YP:Germany

Address

10897 South River Front Parkway, Suite 300, South Jordan, UT, USA, 84095

Website

https://www.healthcatalyst.com

Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Executives

Linda Llewelyn	officer: Chief People Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Jason Alger	officer: Chief Accounting Officer	C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Benjamin Landry	officer: General Counsel	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Matthew Kolb	director	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Bryan Truman Hunt	officer: Chief Financial Officer	C/O HEALTH CATALYST, 3165 MILLROCK DR #400, SALT LAKE CITY UT 84121
Daniel D. Burton	director, officer: Chief Executive Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anne Marie Bickmore	officer: COO and Chief Product Officer	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Kevin Lee Freeman	officer: Chief Growth Officer	C/O HEALTH CATALYST, INC., 10897 SOUTH RIVER FRONT PARKWAY #300, SOUTH JORDAN UT 84095
Daniel H. Orenstein	officer: General Counsel	311 ARSENAL STREET, WATERTOWN MA 02472
Duncan Gallagher	director	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Paul Horstmeier	officer: Chief Operating Officer	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Bryan Richard Hinton	officer: Chief Technology Officer	C/O HEALTH CATALYST, 10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN UT 84095
Nelli James Patrick Jr.	officer: Chief Financial Officer	C/O HEALTH CATALYST, INC., 3165 E.MILLROCK DRIVE #400, SALT LAKE CITY UT 84121
Anita Pramoda	director	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Timothy G. Ferris	director	C/O HEALTH CATALYST, INC., 3165 E. MILLROCK DRIVE, #400, SALT LAKE CITY UT 84121